# PathoGenius: Advanced Drug Discovery and Development Solution

![PathoGenius Logo](pathogenius_logo.png)

## Table of Contents
- [Introduction](#introduction)
- [Problem Statement](#problem-statement)
- [Key Modules](#key-modules)
- [Challenges Addressed](#challenges-addressed)
- [Social Responsibility](#social-responsibility)
- [Business Opportunities](#business-opportunities)
- [Comprehensive Dataset](#comprehensive-dataset)
- [Getting Started](#getting-started)
- [Contributing](#contributing)
- [License](#license)

## Introduction

PathoGenius is a revolutionary web-based and extended reality (XR) solution powered by advanced machine learning algorithms. It aims to facilitate a comprehensive exploration of pharmaceutical properties, intricate drug-pathogen interactions, and their molecular-level repercussions. Our project addresses critical challenges within the drug discovery and development process, with a focus on antimicrobial resistance and mutation-inclusive drug discovery.

## Problem Statement

Cutting-edge technology in healthcare is in high demand due to evolving healthcare trends and growing populations. PathoGenius seeks to address the following major challenges within the Indian and Global Healthcare systems:

1. *Antimicrobial Resistance*: Antibiotic resistance poses a significant threat to global health, food security, and development. PathoGenius aims to combat this challenge by exploring novel drug mechanisms.

2. *Conservation of Drug Target Structures*: Maintaining drug and target structures in the face of mutations is crucial for effective drug discovery.

3. *Access to Drug Target Structures*: Ensuring access to 2D and 3D structural insights for drug discovery, which can be limited.

## Key Modules

PathoGenius is built on four pivotal modules:

1. *VR Research Lab*: An immersive VR research environment for generating 2D and 3D structural insights based on Canonical Smiles of target and drug compounds.

2. *Drug-Target Interaction Analysis*: Leveraging machine learning and datasets like ChEMBL to elucidate how drugs interact with specific targets in pathogens, providing valuable insights into novel drug mechanisms.

3. *Drug Discovery*: Predicting the most effective and active drugs for specific targets by leveraging the ChEMBL dataset.

4. *Mutation-Inclusive Drug Discovery*: Empowering precision medicine by predicting drug efficacy against mutating targets, driven by alterations in viral and bacterial binding sites.

## Challenges Addressed

1. *Antimicrobial Resistance*: PathoGenius addresses the growing threat of antibiotic resistance, making previously treatable infections more difficult to manage.

2. *Conservation of Drug Target Structures*: We tackle the challenge of preserving drug and target structures amid genetic mutations.

3. *Access to Drug Target Structures*: PathoGenius ensures access to crucial structural insights for drug discovery.

## Social Responsibility

PathoGenius recognizes its social responsibility by:

1. Contributing to *Global Health Impact*: Addressing the global challenge of antibiotic resistance, a severe threat to public health worldwide.

2. Embracing a *Holistic Approach*: Going beyond profitability to build a safer and healthier world by addressing global challenges.

## Business Opportunities

1. *Market Opportunity*: PathoGenius capitalizes on the rising concern of antibiotic resistance and the demand for more effective pharmaceuticals.

2. *Competitive Advantage*: Our unique blend of machine learning, VR technology, and data analysis sets us apart, attracting pharmaceutical companies, research institutions, and investors.

3. *Long-term Sustainability*: By aiding the development of effective antibiotics and pharmaceuticals, PathoGenius establishes itself as a long-term player in the drug development ecosystem.

4. *Data Monetization*: The platform generates vast amounts of data that can be monetized through anonymized data sales to pharmaceutical companies and research institutions for market insights.

## Comprehensive Dataset

PathoGenius utilizes the comprehensive ChEMBL dataset, a curated chemical database of bioactive molecules with drug-inducing properties. This dataset is maintained by the European Bioinformatics Institute (EBI), European Molecular Biology Laboratory (EMBL).

## Getting Started

To get started with PathoGenius, please refer to the [documentation](docs/) and follow the installation instructions.

## Contributing

We welcome contributions from the community. If you're interested in contributing, please review our [Contribution Guidelines](CONTRIBUTING.md).

## License

PathoGenius is licensed under the [MIT License](LICENSE).
